While real-world evidence (RWE) is a powerful tool in the health industry, it’s also raised some concerns about personal privacy.
RWE is comprised of data netted outside traditional randomized trials, and continues to see rapid growth in the industry. According to a Managed Care Magazine report, “half of the world’s 1,800 clinical studies involving RWE since 2006 have been started in the last three years.”
Managed Care Magazine was citing a Reuters report.
But concerns are mounting over the sheer volume of data available as tech giants like Apple, Amazon and Alphabet are looking to enter the health care game.
“Some campaigners and academics worry such data will be used primarily as a commercial too by drugmakers and may intrude upon patients’ privacy,” according to the report.